Biology of Parkin and Its Role in Parkinson's Disease
Biology of Parkin and Its Role in Parkinson's Disease
批准号:
8540519
负责人:
Ted M. Dawson
金额:
$12.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2014-07-31
关键词:
ABL1 geneAccountingAnimal ModelAutopsyBiologyBrainCenters of Research ExcellenceDataEvaluationFailureGenerationsGeneticHumanIn VitroInstructionKnock-outLeadMediatingModelingModificationMolecularMutationNeurodegenerative DisordersOxidative StressParkin geneParkinson DiseasePathogenesisPatientsPhosphorylationPhosphotransferasesPhysiologicalPlayPost-Translational Protein ProcessingPrincipal InvestigatorProcessProtein Tyrosine KinaseReceptor Protein-Tyrosine KinasesRoleStressSubstantia nigra structureTestingTherapeuticToxic effectTransgenic MiceTyrosine PhosphorylationUbiquitin-Proteasomal PathwayUbiquitinationalpha synucleinc-abl Proto-Oncogenescell killingdisease-causing mutationdopaminergic neuronin vivoin vivo Modelinsightloss of function mutationneurorestorationnew therapeutic targetnitrosative stressnovelnovel therapeuticsoverexpressionparkin gene/proteinpreventreceptorresearch studysynucleinopathyubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project 1: Biology of Parkin and Its Role in Parkinson's Disease
Mutations in the parkin gene play a prominent role in Parkinson's disease (PD) as mutations in parkin are the
main genetic cause of autosomal recessive PD and mutations in parkin also appear to play a role in familial
PD. Parkin plays a pivotal role in the ubiquitin proteasomal pathway (UPP) by functioning as an ubiquitin E3
ligase. Most disease causing mutations of parkin are thought to be loss of function mutations that ultimately
lead to the absence of ubiquitination and the subsequent failure of UPP-mediated degradation of parkin
substrates. Thus, the abnormal accumulation of parkin substrates could play a role in the demise of
substantia nigra dopaminergic neurons in patients with parkin mutations. Moreover, inactivation of parkin
through dopaminergic and oxidative and nitrosative stress may play a role in sporadic PD. The stress
activated non-receptor tyrosine kinase c-Abl phosphorylates and inactivates parkin and may play a critical
role in sporadic PD by inactivating parkin. We propose to characterize the role of c-Abl mediated inactivation
of parkin and its relationship to oxidative and nitrosative stress in sporadic PD as well as the role of parkin
substrates in the pathogenesis of PD. Understanding the function and role of c-Abl and oxidative/nitrosative
stress mediated inactivation of parkin may provide novel therapeutics targets to prevent the toxic effects of
parkin deficiency in the degenerative process of PD.
RELEVANCE (See instructions):
Parkinson Disease (PD) is common neurodegenerative disease with no proven neuroprotective or
neurorestorative therapy. Understanding the molecular mechanisms by which parkin inactivation leads to
PD may provide novel therapeutic opportunities to maintain parkin in a catalytically active neuroprotective
state.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BIOMARKER DISCOVERY AND VALIDATION IN PSP
-
批准号:9750090
-
项目类别:
-
资助金额:$94.4万
-
财政年份:2018
-
负责人:Ted M. Dawson
-
依托单位:
Biomarker Discovery and Validation in Parkinson's Disease
-
批准号:9269667
-
项目类别:
-
资助金额:$66.04万
-
财政年份:2017
-
负责人:Ted M. Dawson
-
依托单位:
Administrative Core
-
批准号:8882841
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2014
-
负责人:Ted M. Dawson
-
依托单位:
Biology of Parkin and It's Role in Parkinson's Disease
-
批准号:8882845
-
项目类别:
-
资助金额:$41.31万
-
财政年份:2014
-
负责人:Ted M. Dawson
-
依托单位:
cell Function & Pathophysiology Project
-
批准号:8294095
-
项目类别:
-
资助金额:$18.41万
-
财政年份:2012
-
负责人:Ted M. Dawson
-
依托单位:
Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease
-
批准号:9116479
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2012
-
负责人:Ted M. Dawson
-
依托单位:
Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease
-
批准号:9143805
-
项目类别:
-
资助金额:$87.71万
-
财政年份:2012
-
负责人:Ted M. Dawson
-
依托单位:
Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease
-
批准号:8740577
-
项目类别:
-
资助金额:$86.84万
-
财政年份:2012
-
负责人:Ted M. Dawson
-
依托单位:
Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease
-
批准号:8472291
-
项目类别:
-
资助金额:$60.98万
-
财政年份:2012
-
负责人:Ted M. Dawson
-
依托单位:
Johns Hopkins Medicine Biomarker Discovery in Parkinson's Disease
-
批准号:8554394
-
项目类别:
-
资助金额:$75.01万
-
财政年份:2012
-
负责人:Ted M. Dawson
-
依托单位:
Poly (ADP-Ribose) and AIF in Neuronal Injury
-
批准号:8601884
-
项目类别:
-
资助金额:$66.3万
-
财政年份:2010
-
负责人:Ted M. Dawson
-
依托单位:
Poly (ADP-Ribose) and AIF in Neuronal Injury
-
批准号:8213721
-
项目类别:
-
资助金额:$66.97万
-
财政年份:2010
-
负责人:Ted M. Dawson
-
依托单位:
Poly (ADP-Ribose) and AIF in Neuronal Injury
-
批准号:8417717
-
项目类别:
-
资助金额:$64.63万
-
财政年份:2010
-
负责人:Ted M. Dawson
-
依托单位:
Poly (ADP-Ribose) and AIF in Neuronal Injury
-
批准号:8073557
-
项目类别:
-
资助金额:$66.97万
-
财政年份:2010
-
负责人:Ted M. Dawson
-
依托单位:
Poly (ADP-Ribose) and AIF in Neuronal Injury
-
批准号:7986098
-
项目类别:
-
资助金额:$67.65万
-
财政年份:2010
-
负责人:Ted M. Dawson
-
依托单位:
Transgenic and Neurobehavior Core
-
批准号:7664247
-
项目类别:
-
资助金额:$18.34万
-
财政年份:2009
-
负责人:Ted M. Dawson
-
依托单位:
UNDERSTANDING NO SIGNALING RESULTING IN NEUROPROTECTION.
-
批准号:7286956
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2007
-
负责人:Ted M. Dawson
-
依托单位:
Reversible and Temporally Inducible LRRK2 Knockout Mice
-
批准号:7229920
-
项目类别:
-
资助金额:$21.47万
-
财政年份:2006
-
负责人:Ted M. Dawson
-
依托单位:
Reversible and Temporally Inducible LRRK2 Knockout Mice
-
批准号:7028494
-
项目类别:
-
资助金额:$18.37万
-
财政年份:2006
-
负责人:Ted M. Dawson
-
依托单位:
Models of Familial Parkinson's Disease: PINK1
-
批准号:7026996
-
项目类别:
-
资助金额:$18.45万
-
财政年份:2005
-
负责人:Ted M. Dawson
-
依托单位:
海外基金